Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs : Averting cytotoxicity by alloreactive T lymphocytes

K Haga; N. A Lemp; J. C Cicciarelli; C. R Logg; J Nagashima; E FAURE-KUMAR; G. G Gomez; C. A Kruse; R Mendez; R Stripecke; N. A Kasahara

doi:10.1016/j.transproceed.2006.10.158

Back

Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs : Averting cytotoxicity by alloreactive T lymphocytes

Conference proceeding

Open access

Peer reviewed

Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs : Averting cytotoxicity by alloreactive T lymphocytes

K Haga, N. A Lemp, J. C Cicciarelli, C. R Logg, J Nagashima, E FAURE-KUMAR, G. G Gomez, C. A Kruse, R Mendez, R Stripecke, …

Transplantation proceedings, Vol.38(10), pp.3184-3188

World transplant congress 2006, Hynes convention center, Boston, Massachusetts, July 22-27, 2006

2006

DOI: https://doi.org/10.1016/j.transproceed.2006.10.158

PMCID: PMC1868890

PMID: 17175217

Abstract

Biological and medical sciences

Fundamental and applied biological sciences. Psychology

Fundamental immunology

Medical sciences

Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases

Tissue, organ and graft immunology

Files and links (1)

url

https://doi.org/10.1016/j.transproceed.2006.10.158View

Published (Version of record) Open

Metrics

5 Record Views

25 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.161 Virology - Identification & Sequencing; 1.161.479 Adenovirus
Web Of Science research areas: Immunology; Surgery; Transplantation
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Permanent, lowered HLA class I expression using lentivirus vectors with shRNA constructs : Averting cytotoxicity by alloreactive T lymphocytes
Creators: K Haga - Department of Medicine, University of California at Los Angeles, United States
N. A Lemp - Department of Medicine, University of California at Los Angeles, United States
J. C Cicciarelli - Department of Medicine, University of California at Los Angeles, United States
C. R Logg - Department of Medicine, University of California at Los Angeles, United States
J Nagashima - Department of Medicine, University of California at Los Angeles, United States
E FAURE-KUMAR - Department of Medicine, University of California at Los Angeles, United States
G. G Gomez - Institute for Molecular Medicine, San Diego, California, United States
C. A Kruse - Institute for Molecular Medicine, San Diego, California, United States
R Mendez - National Institute of Transplantation, Los Angeles, La Jolla, United States
R Stripecke - Department of Medicine, University of California at Los Angeles, United States
N. A Kasahara - Department of Medicine, University of California at Los Angeles, United States
Publication Details: Transplantation proceedings, Vol.38(10), pp.3184-3188
Conference: World transplant congress 2006, Hynes convention center, Boston, Massachusetts, July 22-27, 2006
Publisher: Elsevier Science
Language: English
Resource Type: Conference proceeding
PMID: 17175217
PMCID: PMC1868890
Record Identifier: 991031613529402976